AKT1 E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
Rudolph, Marion, Anzeneder, Tobias, Schulz, Anke, Beckmann, Georg, Byrne, Annette T., Jeffers, Michael, Pena, Carol, Politz, Oliver, Köchert, Karl, Vonk, Richardus, Reischl, Joachim
Published in BMC cancer (11.08.2016)
Published in BMC cancer (11.08.2016)
Get full text
Journal Article
Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
Kirchhof, Paulus, Ezekowitz, Michael D., Purmah, Yanish, Schiffer, Sonja, Meng, Isabelle L., Camm, A. John, Hohnloser, Stefan H., Schulz, Anke, Wosnitza, Melanie, Cappato, Riccardo
Published in TH open : companion journal to thrombosis and haemostasis (01.01.2020)
Published in TH open : companion journal to thrombosis and haemostasis (01.01.2020)
Get full text
Journal Article
Performing Meta-analyses with Very Few Studies
Schulz, Anke, Schürmann, Christoph, Skipka, Guido, Bender, Ralf
Published in Methods in molecular biology (Clifton, N.J.) (2022)
Published in Methods in molecular biology (Clifton, N.J.) (2022)
Get more information
Journal Article
AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
Rudolph, Marion, Anzeneder, Tobias, Schulz, Anke, Beckmann, Georg, Byrne, Annette T, Jeffers, Michael, Pena, Carol, Politz, Oliver, Köchert, Karl, Vonk, Richardus, Reischl, Joachim
Published in BMC cancer (11.08.2016)
Published in BMC cancer (11.08.2016)
Get full text
Journal Article
AKT1E17K mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection
Rudolph, Marion, Anzeneder, Tobias, Schulz, Anke, Beckmann, Georg, Byrne, Annette T, Jeffers, Michael, Pena, Carol, Politz, Oliver, Köchert, Karl, Vonk, Richardus, Reischl, Joachim
Published in BMC cancer (11.08.2016)
Published in BMC cancer (11.08.2016)
Get full text
Journal Article
Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
Santin, Alessandro D, Vergote, Ignace, González-Martín, Antonio, Moore, Kathleen, Oaknin, Ana, Romero, Ignacio, Diab, Sami, Copeland, Larry J, Monk, Bradley J, Coleman, Robert L, Herzog, Thomas J, Siegel, Jonathan, Kasten, Linda, Schlicker, Andreas, Schulz, Anke, Köchert, Karl, Walter, Annette O, Childs, Barrett H, Elbi, Cem, Bulat, Iurie
Published in International journal of gynecological cancer (01.04.2023)
Published in International journal of gynecological cancer (01.04.2023)
Get full text
Journal Article
Exploratory biomarker analyses of the single-arm, phase 2 study of regorafenib plus nivolumab in patients (pts) with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC)
Fakih, Marwan, Raghav, Kanwal Pratap Singh, Chang, David Z., Larson, Timothy, Cohn, Allen Lee, Huyck, Timothy K., Cosgrove, David, Fiorillo, Joseph A., D'Adamo, David R., Hammell, Amy, Sharma, Neelesh, Coppieters, Sabine, Schulz, Anke, Seidel, Henrik, Herpers, Matthias, Soares Viana de Oliveira, Carolina, Paulson, Andrew Scott, Wang, Ying A.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Abstract LB523: Biomarker assessment of PTEN protein expression and gene expression profiling (GEP) in a phase III study of copanlisib in combination with rituximab in patients with indolent non-Hodgkin lymphoma (iNHL)
Chaturvedi, Shalini, Schulz, Anke, Soler, Lidia Mongay, Childs, Barrett H., Matasar, Matthew, Zinzani, Pier Luigi
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA)
Miyazawa, Kazuo, Pastori, Daniele, Hammerstingl, Christoph, Cappato, Riccardo, Meng, Isabelle Ling, Kramer, Frank, Cohen, Ariel, Schulz, Anke, Eickels, Martin van, Lip, Gregory Y H, Marin, Francisco
Published in Annals of medicine (Helsinki) (18.08.2018)
Published in Annals of medicine (Helsinki) (18.08.2018)
Get more information
Journal Article
VP31 Searching Non-English Literature For HTA Reports May Be Unnecessary
Schell, Lisa, Hausner, Elke, Rodenhäuser, Lina, Assall, Oliver, Schulz, Anke, Sieben, Wiebke, van der Leck, Kerstin, Sauerland, Stefan
Published in International journal of technology assessment in health care (2019)
Published in International journal of technology assessment in health care (2019)
Get full text
Journal Article
Sharing pharma compounds with academia: experiences with providing vitamin D receptor ligands
Schmitz, Arndt A., Hackethal, Sandra, Schulz, Anke, May, Ekkehard, Steinmeyer, Andreas, Zügel, Ulrich, Asadullah, Khusru
Published in Nature reviews. Drug discovery (01.04.2015)
Published in Nature reviews. Drug discovery (01.04.2015)
Get full text
Journal Article
Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer
Van Laethem, Jean-Luc, Riess, Hanno, Jassem, Jacek, Haas, Michael, Martens, Uwe M., Weekes, Colin, Peeters, Marc, Ross, Paul, Bridgewater, John, Melichar, Bohuslav, Cascinu, Stefano, Saramak, Piotr, Michl, Patrick, Van Brummelen, David, Zaniboni, Alberto, Schmiegel, Wollf, Dueland, Svein, Giurescu, Marius, Garosi, Vittorio L., Roth, Katrin, Schulz, Anke, Seidel, Henrik, Rajagopalan, Prabhu, Teufel, Michael, Childs, Barrett H.
Published in Targeted oncology (01.02.2017)
Published in Targeted oncology (01.02.2017)
Get full text
Journal Article
Abstract 5239: KRAS wild-type status as detected by circulating tumor DNA analysis may be a prognostic or predictive factor for clinical benefit in patients with unresectable, locally advanced or metastatic pancreatic cancer (PC) treated with the MEK inhibitor refametin
Teufel, Michael, Van Laethem, Jean-Luc, Riess, Hanno, Giurescu, Marius, Garosi, Vittorio L., Schulz, Anke, Vonk, Richardus, Seidel, Henrik, Reischl, Joachim, Childs, Barrett H.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies
Muysers, Christoph, Dmitrienko, Alex, Kulmann, Hermann, Kirsch, Bodo, Lippert, Susanne, Schmelter, Thomas, Schulz, Anke, Mentenich, Nicole, Schmitz, Heinz, Schaefers, Matthias, Meinhardt, Gerold, Keil, Thomas, Roll, Stephanie
Published in Therapeutic innovation & regulatory science (01.05.2020)
Published in Therapeutic innovation & regulatory science (01.05.2020)
Get full text
Journal Article
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies
Muysers, Christoph, Dmitrienko, Alex, Kulmann, Hermann, Kirsch, Bodo, Lippert, Susanne, Schmelter, Thomas, Schulz, Anke, Mentenich, Nicole, Schmitz, Heinz, Schaefers, Matthias, Meinhardt, Gerold, Keil, Thomas, Roll, Stephanie
Published in Therapeutic innovation & regulatory science (16.06.2019)
Published in Therapeutic innovation & regulatory science (16.06.2019)
Get full text
Journal Article
Electrospray ionization mass spectrometric investigations of α-dicarbonyl compounds—Probing intermediates formed in the course of the nonenzymatic browning reaction of l-ascorbic acid
Schulz, Anke, Trage, Claudia, Schwarz, Helmut, Kroh, Lothar W.
Published in International journal of mass spectrometry (01.05.2007)
Published in International journal of mass spectrometry (01.05.2007)
Get full text
Journal Article
Abstract 569: AKT1 (E17K) mutation: coexistence with oncogenic alterations, prevalence, and correlation to clinical parameter in a large series of breast cancer patients
Rudolph, Marion, Anzeneder, Tobias, Ocker, Matthias, Lagkadinou, Eleni, Politz, Oliver, Michels, Martin, Schulz, Anke, Beckmann, Georg, Teufel, Michael, Seidel, Henrik, Soong, Richie, Bodenmüller, Heinz, Ohlms, Ulla, Asadullah, Khusru, Reischl, Joachim
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Published in Cancer research (Chicago, Ill.) (01.10.2014)
Get full text
Journal Article
Phase II study of the MEK inhibitor refametinib (BAY 86-9766) in combination with gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer: Biomarker results
Riess, Hanno, Van Laethem, Jean-Luc, Martens, Uwe Marc, Heinemann, Volker, Michl, Patrick, Peeters, Marc, Van Brummelen, David, Weekes, Colin D., Dueland, Svein, Schmiegel, Wolff H., Giurescu, Marius, Garosi, Vittorio Luigi, Schulz, Anke, Seidel, Henrik, Childs, Barrett H., Teufel, Michael
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase II study of refametinib (BAY 86-9766), an allosteric dual MEK 1/2 inhibitor, and gemcitabine in patients with unresectable, locally advanced, or metastatic pancreatic cancer
Van Laethem, Jean-Luc, Jassem, Jacek, Heinemann, Volker, Weekes, Colin D., Bridgewater, John A., Cascinu, Stefano, Melichar, Bohuslav, Peeters, Marc, Ross, Paul J., Saramak, Piotr, Giurescu, Marius, Garosi, Vittorio Luigi, Roth, Katrin, Schulz, Anke, Teufel, Michael, Childs, Barrett H., Riess, Hanno
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Cytokeratin-19 as a biomarker in urine and in serum for the diagnosis of endometriosis - a prospective study
Kuessel, Lorenz, Jaeger-Lansky, Agnes, Pateisky, Petra, Rossberg, Nora, Schulz, Anke, Schmitz, Arndt A. P., Staudigl, Christine, Wenzl, René
Published in Gynecological endocrinology (01.01.2014)
Published in Gynecological endocrinology (01.01.2014)
Get full text
Journal Article